Tue, June 14, 2022

Ashwani Verma Initiated (TEVA) at Hold and Held Target at $10 on, Jun 14th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. hold-and-held-target-at-10-on-jun-14th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Ashwani Verma of UBS, Initiated "Teva Pharmaceutical Industries Limited" (TEVA) at Hold and Held Target at $10 on, Jun 14th, 2022.

Ashwani has made no other calls on TEVA in the last 4 months.



There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 2 agree with Ashwani's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jason Gerberry of "B of A Securities" Upgraded from Sell to Hold and Held Target at $9 on, Tuesday, May 17th, 2022
  • Nathan Rich of "Goldman Sachs" Maintained at Hold with Decreased Target to $9 on, Thursday, May 12th, 2022


These are the ratings of the 2 analyists that currently disagree with Ashwani


  • David Amsellem of "Piper Sandler" Downgraded from Hold to Sell and Decreased Target to $7 on, Wednesday, May 4th, 2022
  • Balaji Prasad of "Barclays" Upgraded from Hold to Buy and Increased Target to $13 on, Tuesday, April 5th, 2022